Top compounds associated with response to IPO4


Feature Type Standardized
Nominal ANOVA
mRNA Bleomycin CTRPv2 pan-cancer AAC 0.053 0.2
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.048 0.2
mRNA importazole CTRPv2 pan-cancer AAC -0.053 0.2
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA Dasatinib FIMM pan-cancer AAC 0.22 0.2
mRNA C6-ceramide CTRPv2 pan-cancer AAC -0.051 0.2
mRNA CD-437 CTRPv2 pan-cancer AAC 0.044 0.2
Download CSV